Friday, July 15, 2016

Orphan drug status for Crestor?

Note the article in the New York Times by Andrew Pollack about Crestor titled
AstraZeneca Pushes to Protect Crestor From Generic Competition

Note separately the article by Murphy: Unintended Effects of Orphan Product Designation for Rare Neurological Diseases, especially Table 2: Blockbuster drugs that have obtained orphan drug designation


Post a Comment

<< Home